文献速递痛风与晶体性关节病

血清尿酸水平预测非痛风性内侧膝骨关节炎患者的关节间隙狭窄

Serum Urate Levels Predict Joint Space Narrowing in Non-Gout Patients With Medial Knee Osteoarthritis.
PubMed 文献 · Arthritis Rheumatol · 2017-04-28

OBJECTIVE: The pathogenesis of osteoarthritis (OA) includes both mechanical and inflammatory features. Studies have implicated synovial fluid uric acid (UA) as a potential OA biomarker, possibly reflecting chondrocyte damage.…

要点

  • 血清尿酸与关节间隙狭窄在单变量和多变量分析中均相关。
  • 以6.8 mg/dl为切点分组,高尿酸组关节间隙狭窄更明显。
  • 基线尿酸可区分进展者,但与滑膜体积的相关性在校正后不显著。

核心结论

  • 在无痛风的内侧膝骨关节炎患者中,血清尿酸水平可预测未来关节间隙狭窄,可能作为骨关节炎进展的生物标志物。

研究设计与样本

  • 在0和24个月进行标准化负重固定屈曲后前位膝关节X线检查,计算关节间隙宽度和Kellgren/Lawrence分级。

主要发现

  • 血清尿酸与关节间隙狭窄在单变量分析(r=0.40,P<0.01)和多变量分析(r=0.28,P=0.01)中相关。
  • 以6.8 mg/dl为切点分组,血清尿酸≥6.8 mg/dl者关节间隙狭窄0.90 mm,<6.8 mg/dl者0.31 mm,校正后差异仍显著(P<0.01)。
  • 多变量分析中,基线血清尿酸区分进展者(JSN>0.2 mm)和非进展者(JSN≤0.0 mm)的曲线下面积为0.63(P=0.03),区分快速进展者(JSN>0.5 mm)的曲线下面积为0.62(P=0.05)。
  • 血清尿酸与滑膜体积相关(r=0.44,P<0.01),但控制年龄、性别和体重指数后相关性不显著(r=0.13,P=0.56)。

关键数值与推荐

  • 血清尿酸切点为6.8 mg/dl,即血清尿酸盐溶解度点。
  • 进展者定义为关节间隙狭窄>0.2 mm,快速进展者定义为>0.5 mm,非进展者定义为≤0.0 mm。

临床怎么用

  • 对无痛风的内侧膝骨关节炎患者,可关注基线血清尿酸水平以评估关节间隙狭窄进展风险。
  • 血清尿酸6.8 mg/dl可作为风险分层的参考切点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The pathogenesis of osteoarthritis (OA) includes both mechanical and inflammatory features. Studies have implicated synovial fluid uric acid (UA) as a potential OA biomarker, possibly reflecting chondrocyte damage. Whether serum UA levels reflect/contribute to OA is unknown. We investigated whether serum UA levels predict OA progression in a non-gout knee OA population. METHODS: Eighty-eight patients with medial knee OA (body mass index [BMI] <33 kg/m2 ) but without gout were studied. Baseline serum UA levels were measured in previously banked serum samples. At 0 and 24 months, patients underwent standardized weight-bearing fixed-flexion posteroanterior knee radiography to determine joint space width (JSW) and Kellgren/Lawrence grades. Joint space narrowing (JSN) was calculated as the change in JSW from 0 to 24 months. Twenty-seven patients underwent baseline contrast-enhanced 3T knee magnetic resonance imaging for assessment of synovial volume. RESULTS: Serum UA levels correlated with JSN values in both univariate (r = 0.40, P < 0.01) and multivariate (r = 0.28, P = 0.01) analyses. There was a significant difference in mean JSN after dichotomization at a serum UA cut point of 6.8 mg/dl, the solubility point for serum urate, even after adjustment (JSN of 0.90 mm for a serum UA ≥6.8 mg/dl and 0.31 mm for a serum UA <6.8 mg/dl; P < 0.01). Baseline serum UA levels distinguished progressors (JSN >0.2 mm) and fast progressors (JSN >0.5 mm) from nonprogressors (JSN ≤0.0 mm) in multivariate analyses (area under the receiver operating characteristic curve 0.63 [P = 0.03] and 0.62 [P = 0.05], respectively). Serum UA levels correlated with the synovial volume (r = 0.44, P < 0.01), a possible marker of JSN, although this correlation did not persist after controlling for age, sex, and BMI (r = 0.13, P = 0.56). CONCLUSION: In non-gout patients with knee OA, the serum UA level predicted future JSN and may serve as a biomarker for OA progression.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Krasnokutsky S, Oshinsky C, Attur M, et al. Serum Urate Levels Predict Joint Space Narrowing in Non-Gout Patients With Medial Knee Osteoarthritis. Arthritis Rheumatol. 2017. PMID: 28217895. doi:10.1002/art.40069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。